Scribd
Upload
3 views3 pages

Abstracts

This document discusses the design of a multi-epitope nanoparticle-based vaccine against Mycobacterium tuberculosis, aimed at improving immunization strategies due to the low efficacy of the current BCG vaccine. The proposed vaccine utilizes immune-informatics to identify conserved epitopes and incorporates advanced delivery systems to enhance immune responses. The goal is to create a next-generation vaccine with increased immunogenicity and broader strain coverage compared to existing options.

Uploaded by

Iqra Naeem
Copyright
© All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as DOCX, PDF, TXT or read online on Scribd
3 views3 pages

Abstracts

This document discusses the design of a multi-epitope nanoparticle-based vaccine against Mycobacterium tuberculosis, aimed at improving immunization strategies due to the low efficacy of the current BCG vaccine. The proposed vaccine utilizes immune-informatics to identify conserved epitopes and incorporates advanced delivery systems to enhance immune responses. The goal is to create a next-generation vaccine with increased immunogenicity and broader strain coverage compared to existing options.

Uploaded by

Iqra Naeem
Copyright
© All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as DOCX, PDF, TXT or read online on Scribd

Rational Design of a Multi-Epitope Nanoparticle-Based Vaccine Against Mycobacterium

tuberculosis Using Immuno-informatics and Prime Boost Strategy

Iqra Naeem1, Faisal Siddique1, Fatima Tuz Zahra1, Zarnisha Malik1, Umaima Nadeem1, Abdul
Rehman1

1
Department of Microbiology, Cholistan University of Veterinary and Animal Sciences
Bahawalpur, Pakistan

Abstract:

Since tuberculosis (TB) remains one of the deadliest infectious diseases in the world, improved
immunization strategies are required due to the low efficacy of the Bacillus Calmette-Guérin
(BCG) vaccine. The intracellular persistence and immune evasion tactics of Mycobacterium
tuberculosis necessitate vaccines that can generate robust and long-lasting cellular immunity.
This work proposes the logical design and in silico evaluation of a multi-epitope nanoparticle-
based vaccine that targets conserved immunogenic proteins of M. tuberculosis. The whole-
genome sequences of circulating strains will be analyzed using immune-informatics techniques
to identify conserved T-cell and B-cell epitopes. A subset of epitopes from virulence-associated
and latency-associated antigens will have their antigenicity, population coverage, and
immunogenic potential analyzed. To improve Th1-biased immune responses, a synthetic multi-
epitope construct will be designed with suitable linkers and molecular adjuvant sequences.
Molecular docking and structural modeling will evaluate interactions with innate immune
receptors and major histocompatibility complex (MHC) molecules. To enhance antigen stability
and dendritic cell targeting, the optimized construct will be integrated into a delivery platform
based on nanoparticles. T-cell memory induction, cytokine activation, and anticipated antibody
production will all be assessed through immune response simulation. To speed up the
development of preclinical candidates, the suggested approach combines sophisticated delivery
systems with computational vaccine design. In comparison to BCG alone, this strategy seeks to
produce a next-generation tuberculosis vaccine with increased immunogenicity, wider strain
coverage, and improved protective potential.

Keywords: Tuberculosis, cellular immunity, immune-informatics, nanoparticle-based multi-


epitope vaccine

You might also like